학술논문
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer.
Document Type
Article
Author
Source
Prostate; Feb2024, Vol. 84 Issue 2, p131-147, 17p
Subject
Language
ISSN
02704137